DAPSONE 8.5% / NIACINAMIDE 2% / SPIRONOLACTONE 5%

Sincerus Florida, LLC🇺🇸 United States

FDA Page

Effective Date: May 9, 2019
Approval ID: 887a6d0f-d338-48b9-e053-2a95a90af2a0
Products: 1 registered
Version: 1

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

DAPSONE 8.5% / NIACINAMIDE 2% / SPIRONOLACTONE 5%

Quick Stats

Total Products1

Labelers2

Label Sections4

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.